ArticleBriefings in bioinformatics2025
Probabilistic-graph-based spatial context-aware framework for interpretable spatial omics denoising and augmentation.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-task spatial distillation reveals cell-type-resolved programmed cell death landscapes in the human kidney.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Spatially resolved omics technologies offer unprecedented insight into tissue organization, yet current analytical methods face challenges in effectively handling technical noise while preserving biological heterogeneity. We present CadaST, an interpretable and unified computational framework that integrates spatially aware feature selection and an adaptive imputation strategy to address this limitation. By inferring the spatial molecular pattern for each feature and conducting pattern-guided aggregation, CadaST effectively denoises and augments spatial omics data while preserving sharp biological boundaries. This gene-centric approach robustly denoises data without the oversmoothing common to other methods. CadaST is versatile and highly effective, outperforming existing methods across diverse spatial technologies. It accurately resolves delicate anatomical layers in the brain, characterizes complex tumor microenvironments, and scales efficiently to large-scale developmental atlases. By providing a more accurate, interpretable, and scalable solution, CadaST represents a significant methodological advance for elucidating the principles of tissue architecture in health and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.